Literature DB >> 18379256

Assessment of vascular permeability in an ovine model of acute lung injury and pneumonia-induced Pseudomonas aeruginosa sepsis.

Matthias Lange1, Atsumori Hamahata, Perenlei Enkhbaatar, Aimalohi Esechie, Rhykka Connelly, Yoshimitsu Nakano, Collette Jonkam, Robert A Cox, Lillian D Traber, David N Herndon, Daniel L Traber.   

Abstract

OBJECTIVE: To assess the time changes and mechanism of pulmonary and peripheral vascular permeability in sheep with acute lung injury and sepsis.
DESIGN: Prospective, controlled, randomized trial.
SETTING: University research laboratory.
SUBJECTS: A total of 21 chronically instrumented, adult female sheep.
INTERVENTIONS: Sheep were instrumented with lung and prefemoral lymph fistulas and allocated to either an uninjured control group (n = 5) or sepsis group (n = 5). The sheep in the sepsis group received cotton smoke inhalation injury followed by instillation of Pseudomonas aeruginosa into the lungs. All sheep were mechanically ventilated and fluid resuscitated for the entire duration of the 24-hr experiment. Additional sheep (n = 11) received injury and were killed at different time points for the measurement of vascular endothelial growth factor in lung tissue.
MEASUREMENTS AND MAIN RESULTS: The injury induced a hypotensive-hyperdynamic circulation; increases in pulmonary capillary pressure, net fluid balance, lung and prefemoral lymph flow and protein content, lung water content, abdominal and thoracic fluid and protein content, neutrophil accumulation in the lung, and vascular endothelial growth factor expression in lung tissue; and decreases in PaO2/FiO2 ratio, plasma protein concentration, plasma oncotic pressure, and myocardial contractility.
CONCLUSIONS: Lung edema formation in this model was the result of marked increases in both pulmonary microvascular permeability and pressure. Pulmonary vascular hyperpermeability peaked 12 hrs postinjury and was related to vascular endothelial growth factor overexpression. Early myocardial failure was a potential contributor to the constant increase in pulmonary capillary pressure. The sepsis-induced increase in peripheral microvascular permeability was associated with significant accumulation of fluid and protein in the third space.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379256     DOI: 10.1097/CCM.0b013e318169ef74

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

1.  Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury.

Authors:  Matthias Lange; Csaba Szabo; Perenlei Enkhbaatar; Rhykka Connelly; Eszter Horvath; Atsumori Hamahata; Robert A Cox; Aimalohi Esechie; Yoshimitsu Nakano; Lillian D Traber; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-12       Impact factor: 5.464

2.  Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury.

Authors:  Matthias Lange; Atsumori Hamahata; Daniel L Traber; Rhykka Connelly; Yoshimitsu Nakano; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar
Journal:  Burns       Date:  2012-05-29       Impact factor: 2.744

3.  Time profile of oxidative stress and neutrophil activation in ovine acute lung injury and sepsis.

Authors:  Matthias Lange; Csaba Szabo; Daniel L Traber; Eszter Horvath; Atsumori Hamahata; Yoshimitsu Nakano; Lillian D Traber; Robert A Cox; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar
Journal:  Shock       Date:  2012-05       Impact factor: 3.454

4.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

5.  Minimally invasive colon resection is associated with a transient increase in plasma sVEGFR1 levels and a decrease in sVEGFR2 levels during the early postoperative period.

Authors:  H M C Shantha Kumara; J C Cabot; A Hoffman; M Luchtefeld; M F Kalady; N Hyman; D Feingold; R Baxter; R Larry Whelan
Journal:  Surg Endosc       Date:  2009-01-28       Impact factor: 4.584

Review 6.  Bench-to-bedside review: nitric oxide in critical illness--update 2008.

Authors:  Steven M Hollenberg; Ismail Cinel
Journal:  Crit Care       Date:  2009-07-16       Impact factor: 9.097

7.  Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model.

Authors:  Matthias Lange; Rhykka Connelly; Daniel L Traber; Atsumori Hamahata; Yoshimitsu Nakano; Aimalohi Esechie; Collette Jonkam; Sanna von Borzyskowski; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Perenlei Enkhbaatar
Journal:  Crit Care       Date:  2010-07-05       Impact factor: 9.097

8.  Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury.

Authors:  Matthias Lange; Perenlei Enkhbaatar; Daniel L Traber; Robert A Cox; Sam Jacob; Babu P Mathew; Atsumori Hamahata; Lillian D Traber; David N Herndon; Hal K Hawkins
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

9.  Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy.

Authors:  K Adam Morrow; Cristhiaan D Ochoa; Ron Balczon; Chun Zhou; Laura Cauthen; Mikhail Alexeyev; Katherine M Schmalzer; Dara W Frank; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-04       Impact factor: 5.464

10.  Pulmonary vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis.

Authors:  Collette C Jonkam; Kamna Bansal; Daniel L Traber; Atsumori Hamahata; Marc O Maybauer; Dirk M Maybauer; Robert A Cox; Matthias Lange; Rhykka L Connelly; Lillian D Traber; Clarisse D Djukom; John R Salsbury; David N Herndon; Perenlei Enkhbaatar
Journal:  Crit Care       Date:  2009-02-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.